Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

New GSK venture fund Action Potential joins in SetPoint Medical’s $27mm Series C; adds $15mm

Executive Summary

Several corporate investors--Boston Scientific, Covidien Ventures, and GlaxoSmithKline’s Action Potential Venture Capital (APVC) fund--have joined existing shareholders Morgenthaler Venture Partners, Foundation Medical Partners, and Topspin Partners in a $27mm Series C financing for SetPoint Medical Corp. (vagus nerve stimulation to prompt the body’s natural defense mechanisms against many types of chronic inflammation).
Deal Industry
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies